These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19483148)

  • 1. Advances in improving the quality and flexibility of compound management.
    Janzen WP; Popa-Burke IG
    J Biomol Screen; 2009 Jun; 14(5):444-51. PubMed ID: 19483148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening library evolution through automation of solution preparation.
    Schopfer U; Höhn F; Hueber M; Girod M; Engeloch C; Popov M; Muckenschnabel I
    J Biomol Screen; 2007 Aug; 12(5):724-32. PubMed ID: 17507640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-quality cost-effective compound management support for HTS.
    Zaragoza-Sundqvist M; Eriksson H; Rohman M; Greasley PJ
    J Biomol Screen; 2009 Jun; 14(5):509-14. PubMed ID: 19487769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovation leading the way: application of lean manufacturing to sample management.
    Allen M; Wigglesworth MJ
    J Biomol Screen; 2009 Jun; 14(5):515-22. PubMed ID: 19483142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular library design using multi-objective optimization methods.
    Nicolaou CA; Kannas CC
    Methods Mol Biol; 2011; 685():53-69. PubMed ID: 20981518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound management beyond efficiency.
    Burr I; Winchester T; Keighley W; Sewing A
    J Biomol Screen; 2009 Jun; 14(5):485-91. PubMed ID: 19502566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case study: technology initiative led to advanced lead optimization screening processes at Bristol-Myers Squibb, 2004-2009.
    Zhang L; Cvijic ME; Lippy J; Myslik J; Brenner SL; Binnie A; Houston JG
    Drug Discov Today; 2012 Jul; 17(13-14):733-40. PubMed ID: 22425710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control in combinatorial chemistry: determination of the quantity, purity, and quantitative purity of compounds in combinatorial libraries.
    Yan B; Fang L; Irving M; Zhang S; Boldi AM; Woolard F; Johnson CR; Kshirsagar T; Figliozzi GM; Krueger CA; Collins N
    J Comb Chem; 2003; 5(5):547-59. PubMed ID: 12959555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment analysis in small molecule discovery.
    Merlot C; Domine D; Church DJ
    Curr Opin Drug Discov Devel; 2002 May; 5(3):391-9. PubMed ID: 12058614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind".
    Snowden M; Green DV
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):553-8. PubMed ID: 18600571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of high-throughput screening.
    Mayr LM; Fuerst P
    J Biomol Screen; 2008 Jul; 13(6):443-8. PubMed ID: 18660458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which aspects of HTS are empirically correlated with downstream success?
    Bender A; Bojanic D; Davies JW; Crisman TJ; Mikhailov D; Scheiber J; Jenkins JL; Deng Z; Hill WA; Popov M; Jacoby E; Glick M
    Curr Opin Drug Discov Devel; 2008 May; 11(3):327-37. PubMed ID: 18428086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.